Navigation Links
Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
Date:5/11/2012

PHILADELPHIA, May 11, 2012 /PRNewswire/ --

 

This new Q&A session features industry leaders Dean Kamen  and Dr. Thomas Fogarty  offering their insights into the future of medical device development. Free for attendees at MD&M East Philadelphia on May 23.

On Wednesday, May 23 at 2:30pm, Medical Design & Manufacturing East (MD&M East) will present the special panel, "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen." Led by UBM Canon's Director of Content, Rich Nass, this live Q&A panel will feature renowned inventor Dean Kamen, and MDEA Lifetime Achievement Award winner Dr. Thomas Fogarty.

Mr. Kamen and Dr. Fogarty are two of the most important and innovative minds in the medical device industry today.  Attendees will have the rare opportunity to interact directly with Mr. Kamen and Dr. Fogarty as they answer questions and share their insights into the future of medical device development and technology. This panel is free to all Expo attendees. Complete details and registration information are available at MDMEast.com.

About Dean Kamen

Dean Kamen is an inventor, entrepreneur, and advocate for science and technology. He has more than 440 U.S. and foreign patents and invented the first wearable infusion pump and the first wearable insulin pump for diabetes. Some of the many devices Mr. Kamen has worked on include the HomeChoice™ peritoneal dialysis system, Hydroflex™ surgical irrigation pump, the Crown™ stent, iBOT™ mobility device, and the Segway® Human Transporter. Mr. Kamen was awarded the National Medal of Technology in 2000, the Lemelson-MIT Prize 2002, and has been inducted into the National Inventors Hall of Fame in 2005.

About Dr. Thomas Fogarty

Dr. Thomas Fogarty's vast accomplishments in the medical device industry include having founded or co-founded more than 33 medical companies. Fogarty holds 135 patents on surgical instruments, among them the Fogarty balloon embolectomy catheter which revolutionized vascular surgery, became the first minimally invasive surgical device, and is still commonly used. Before Fogarty invented the arterial embolectomy catheter, up to 50% of patients were dying or losing limbs during surgery to remove blood clots. Fogarty's inventions have saved the lives of millions of people.

About MD&M East Exposition

MD&M East Expo will run from Tuesday, May 22through Thursday, May 24 on the main floor of the Pennsylvania Convention Center. MD&M East provides medical device engineers, R&D, quality, regulatory, design, and manufacturing contact with hundreds of the industry's medical OEM contract service providers, suppliers and consultants. Developers can quickly evaluate and compare end-to-end manufacturing solutions in one single location. Every stage of the product development cycle is represented, from research and design through regulatory approval and end-product marketing. Exposition registration is complimentary to qualified members of the medtech community at http://www.MDMEast.com.

Event Details
MD&M East

Exposition: May 22-24, 2012

Conference: May 21-24, 2012

Pennsylvania Convention Center

1101 Arch Street

Philadelphia, PA 19107

*Special panel "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen" -  Wednesday, May 23, 2:30pm-3:30pm, Innovation Briefs Theater, Booth 589, MD&M East Exhibit Floor

http://www.MDMEast.com

Editorial Contact:

Nannette Nolan
Marketing Manager, Medical Events
UBM Canon
nannette.nolan@ubm.com 
+1-310-996-9468

 



'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Knee Pain? An Exclusive Study Engineers Cartilage to Match Patients Own Tissue
2. PARI Nebulizer & Compressor Used Exclusively in Inspires Phase 3 CF Trial
3. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
4. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
5. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
6. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
7. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
8. The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
9. DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
10. John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden
11. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):